Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy ((ANSWer))
An Observational Study to Collect and Assess Tissue Samples From Subjects With One of Three Neoplastic Conditions (ANSWer)
Sponsor: Notable Labs
Listed as NCT04014764, this observational or N/A phase trial focuses on Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia and remains completed. Sponsored by Notable Labs, it has been updated 14 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
May 2020 — Nov 2020 [monthly]
Recruiting
-
Mar 2020 — May 2020 [monthly]
Recruiting
-
Jan 2020 — Mar 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Jan 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Notable Labs
For direct contact, visit the study record on ClinicalTrials.gov .